Somatic Activation of KIT in Distinct Subtypes of Melanoma
Top Cited Papers
- 10 September 2006
- journal article
- melanoma
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (26) , 4340-4346
- https://doi.org/10.1200/jco.2006.06.2984
Abstract
Purpose: Melanomas on mucosal membranes, acral skin (soles, palms, and nail bed), and skin with chronic sun-induced damage have infrequent mutations in BRAF and NRAS, genes within the mitogen-activated protein (MAP) kinase pathway commonly mutated in melanomas on intermittently sun-exposed skin. This raises the question of whether other aberrations are occurring in the MAP kinase cascade in the melanoma types with infrequent mutations of BRAF and NRAS. Patients and Methods: We analyzed array comparative genomic hybridization data from 102 primary melanomas (38 from mucosa, 28 from acral skin, and 18 from skin with and 18 from skin without chronic sun-induced damage) for DNA copy number aberrations specific to melanoma subtypes where mutations in BRAF and NRAS are infrequent. A narrow amplification on 4q12 was found, and candidate genes within it were analyzed. Results: Oncogenic mutations in KIT were found in three of seven tumors with amplifications. Examination of all 102 primary melanomas found mutations and/or copy number increases of KIT in 39% of mucosal, 36% of acral, and 28% of melanomas on chronically sun-damaged skin, but not in any (0%) melanomas on skin without chronic sun damage. Seventy-nine percent of tumors with mutations and 53% of tumors with multiple copies of KIT demonstrated increased KIT protein levels. Conclusion: KIT is an important oncogene in melanoma. Because the majority of the KIT mutations we found in melanoma also occur in imatinib-responsive cancers of other types, imatinib may offer an immediate therapeutic benefit for a significant proportion of the global melanoma burden.Keywords
This publication has 28 references indexed in Scilit:
- Distinct Sets of Genetic Alterations in MelanomaNew England Journal of Medicine, 2005
- Determinants of BRAF Mutations in Primary MelanomasJNCI Journal of the National Cancer Institute, 2003
- Shaping of tumor and drug-resistant genomes by instability and selectionOncogene, 2003
- Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosaCancer, 2001
- Germline-Activating Mutation in the Kinase Domain of KIT Gene in Familial Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Mutations and Copy Number Increase of HRAS in Spitz Nevi with Distinctive Histopathological FeaturesPublished by Elsevier ,2000
- In VivoDifferentiation of Mast Cells from Acute Myeloid Leukemia Blasts Carrying a Novel Activating Ligand-Independent C-kit MutationBlood Cells, Molecules, and Diseases, 1998
- Chromosomal gains and losses in primary cutaneous melanomas detected by compartive genomic hybridizationJournal of Dermatological Science, 1998
- The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogeneCell, 1988
- The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locusNature, 1988